BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19287977)

  • 1. Fluorescence diagnosis and flat lesions of urothelium: new challenges for pathologists and urologists (Review).
    Compérat E; Conort P; Roupret M; Capron F; Camparo P; Montironi R
    Oncol Rep; 2009 Apr; 21(4):839-44. PubMed ID: 19287977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathologic diagnosis and management of flat lesions of urothelium detected with aminolevulinic acid (Hexvix®)].
    Compérat E; Conort P; Rouprêt M; Camparo P; Mazerolles C
    Prog Urol; 2011 Mar; 21(3):157-65. PubMed ID: 21354032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation.
    Lopez-Beltran A; Cheng L; Andersson L; Brausi M; de Matteis A; Montironi R; Sesterhenn I; van det Kwast KT; Mazerolles C
    Virchows Arch; 2002 Jan; 440(1):3-11. PubMed ID: 11942574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent advances in diagnosis of flat lesions of urinary bladder].
    Cheng L; Xu JW; Teng XD
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):577-81. PubMed ID: 21092582
    [No Abstract]   [Full Text] [Related]  

  • 6. Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features.
    Hodges KB; Lopez-Beltran A; Davidson DD; Montironi R; Cheng L
    Hum Pathol; 2010 Feb; 41(2):155-62. PubMed ID: 19762067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub Group.
    Richards B; Parmar MK; Anderson CK; Ansell ID; Grigor K; Hall RR; Morley AR; Mostofi FK; Risdon RA; Uscinska BM
    Br J Urol; 1991 Apr; 67(4):369-75. PubMed ID: 2032076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [So-called "superficial" bladder tumors. Which classification in 2003? Part 2: Flat urothelial lesions].
    Sibony M; Billerey C
    Ann Pathol; 2003 Feb; 23(1):35-45. PubMed ID: 12743498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
    Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
    Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewis(y) antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder.
    Gunia S; Kakies C; May M; Koch S; Erbersdobler A
    J Clin Pathol; 2011 Aug; 64(8):672-6. PubMed ID: 21512109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic metaplasia of urinary bladder--a case report.
    Masih K; Baksh S
    Indian J Pathol Microbiol; 2004 Apr; 47(2):273-4. PubMed ID: 16295498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratinizing squamous metaplasia of the bladder: a review.
    Ahmad I; Barnetson RJ; Krishna NS
    Urol Int; 2008; 81(3):247-51. PubMed ID: 18931537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer: clinical and pathological profile.
    Lopez-Beltran A
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):95-109. PubMed ID: 18815924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review. Non-papillary urothelial lesions of the urinary bladder: morphological classification and immunohistochemical markers.
    Petraki CD; Sfikas CP
    In Vivo; 2008; 22(4):493-501. PubMed ID: 18712178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperplastic-proliferative and preneoplastic lesions of the bladder urothelium (author's transl)].
    Mattarozzi A; Zaniboni P; Zanella L; Bacchini P; Bertoni F
    Pathologica; 1981; 73(1026):597-612. PubMed ID: 7312433
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.
    Hartmann A; Moser K; Kriegmair M; Hofstetter A; Hofstaedter F; Knuechel R
    Am J Pathol; 1999 Mar; 154(3):721-7. PubMed ID: 10079249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiprobe FISH for enhanced prediction of recurrent bladder cancer].
    Zellweger T; Benz G; Herzog M; Grilli B; Mihatsch MJ; Gasser TC; Bubendorf L
    Verh Dtsch Ges Pathol; 2004; 88():194-8. PubMed ID: 16892552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder.
    Montironi R; Lopez-Beltran A; Scarpelli M; Mazzucchelli R; Cheng L
    Histopathology; 2008 Dec; 53(6):621-33. PubMed ID: 18422972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of random mucosal biopsies in patients with bladder cancer: analysis of 117 cases].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1990 Mar; 28(3):181-3, 191. PubMed ID: 2379431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.